Chemoinformaics analysis of 3,4-Dihydroxy-2-Methylenebutanoic-Acid
| Molecular Weight | 146.142 | nRot | 3 |
| Heavy Atom Molecular Weight | 136.062 | nRig | 2 |
| Exact Molecular Weight | 146.058 | nRing | 0 |
| Solubility: LogS | 0.19 | nHRing | 0 |
| Solubility: LogP | -1.002 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 19.8959 |
| nHD | 2 | BPOL | 12.6361 |
| QED | 0.398 |
| Synth | 3.264 |
| Natural Product Likeliness | 2.048 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.113 |
| CACO-2 | -4.792 |
| MDCK | 0.00253852 |
| BBB | 0.659 |
| PPB | 0.141563 |
| VDSS | 0.479 |
| FU | 0.778936 |
| CYP1A2-inh | 0.051 |
| CYP1A2-sub | 0.272 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.36 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.083 |
| CYP2d6-inh | 0.004 |
| CYP2d6-sub | 0.173 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.17 |
| CL | 3.948 |
| T12 | 0.869 |
| hERG | 0.011 |
| Ames | 0.243 |
| ROA | 0.548 |
| SkinSen | 0.326 |
| Carcinogencity | 0.033 |
| EI | 0.876 |
| Respiratory | 0.855 |
| NR-Aromatase | 0.129 |
| Antiviral | No |
| Prediction | 0.962085 |